PERSPECTA

News from every angle

← Back to headlines

Wells Fargo Cuts Price Target on Sarepta Therapeutics (SRPT)

Wells Fargo has reduced its price target for Sarepta Therapeutics (SRPT) from $45 to $38.

1 Mar, 09:27 — 1 Mar, 09:27
PostShare

Sources

Showing 1 of 1 sources
YahooMostly Factual47d ago

Wells Fargo Cuts PT on Sarepta Therapeutics (SRPT) to $38 From $45

Read full article →

Related Stories

Oil Jumps Above $100 After US-Iran Talks Fail

just now

Swedish Financial Authority Warns Against Holiday Loans

12m ago

Sanctions Against Iran and Russia and Their Impact on the British Economy

21m ago

Sharp Rise in Taxpayer Appeals to Greek Tax Authority

21m ago